Skip to main content

Advertisement

Log in

Locally advanced head and neck cancer

  • Published:
Current Treatment Options in Oncology Aims and scope Submit manuscript

Opinion statement

The simultaneous administration of chemotherapy and radiation has produced a significant impact on the treatment of advanced squamous cell carcinomas of the head and neck. Although no single regimen has emerged as the “standard” approach, recent trials have consistently demonstrated the superiority of combined treatment programs over radiotherapy alone for local tumor control and overall survival. More-over, multimodal treatment has emerged with important ancillary goals of organ preservation, improved cosmesis, and enhancement of quality of life. With improving survival in all stages of disease, much attention can be given to identifying effective measures to reduce the risk of metachronous primary cancers in this high-risk group.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References and Recommended Reading

  1. Vokes EE, Weichselbaum RR, Lippman SM, et al.: Head and neck cancer. N Engl J Med 1993, 328:184–194.

    Article  PubMed  CAS  Google Scholar 

  2. Hong WK, Lippman SM, Wolf GT: Recent advances in head and neck cancer-larynx preservation and cancer chemoprevention: the Seventeenth Annual Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res 1993, 53:5113–5120.

    PubMed  CAS  Google Scholar 

  3. Hong WK, Bromer RH, Amato DA, et al.: Patterns of relapse in locally advanced head and neck cancer patients who achieved complete remission after combined modality therapy. Cancer 1985, 56:1242–1245.

    Article  PubMed  CAS  Google Scholar 

  4. Tupchong L, Scott CB, Blitzer PH, et al.: Randomized study of preoperative versus postoperative radiation therapy in advanced head and neck carcinoma: long-term follow-up of RTOG study 73–03. Int J Radiat Oncol Biol Phys 1991, 20:21–28.

    PubMed  CAS  Google Scholar 

  5. Brennan JA, Mao L, Hruban RH, et al.: Molecular assess-ment of histopathological staging in squamous-cell carcinoma of the head and neck. N Engl J Med 1995, 332:429–435.

    Article  PubMed  CAS  Google Scholar 

  6. The Department of Veterans Affairs Laryngeal Cancer Study Group: Induction chemotherapy plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1991, 324:1685–1690.

    Article  Google Scholar 

  7. Lefebvre JL, Chevalier D, Luboinski B, et al.: Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst 1996, 88:890–899.

    Article  PubMed  CAS  Google Scholar 

  8. Vokes EE: Interactions of chemotherapy and radiation. Semin Oncol 1993, 20:70–79.

    PubMed  CAS  Google Scholar 

  9. Lo TC, Wiley Jr AL, Ansfield FJ, et al.: Combined radiation therapy and 5-fluorouracil for advanced squamous cell carcinoma of the oral cavity and oropharynx: a randomized study. Am J Roentgenol 1976, 126:229–235.

    CAS  Google Scholar 

  10. Shanta V, Krishnamurthi S: Combined bleomycin and radiotherapy in oral cancer. Clin Radiol 1980, 31:617–620.

    Article  PubMed  CAS  Google Scholar 

  11. Fu KK, Phillips TL, Silverberg IJ, et al.: Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: update of a Northern California Oncology Group randomized trial. J Clin Oncol 1987, 5:1410–1418.

    PubMed  CAS  Google Scholar 

  12. Gupta NK, Pointon RC, Wilkinson PM: A randomised clinical trial to contrast radiotherapy with radio-therapy and methotrexate given synchronously in head and neck cancer. Clin Radiol 1987, 38:575–581.

    Article  PubMed  CAS  Google Scholar 

  13. Browman GP, Cripps C, Hodson DI, et al.: Placebo-controlled randomized trial of infusional fluorouracil during standard radiotherapy in locally advanced head and neck cancer. J Clin Oncol 1994, 12:2648–2653.

    PubMed  CAS  Google Scholar 

  14. Haffty BG, Son YH, Papac R, et al.: Chemotherapy as an adjunct to radiation in the treatment of squamous cell carcinoma of the head and neck: results of the Yale mitomycin randomized trials. J Clin Oncol 1997, 15:268–276.

    PubMed  CAS  Google Scholar 

  15. Bachaud J, Cohen-Jonathan E, Alzieu C, et al.:Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced head and neck carcinoma: final report of a randomized trial. Int J Radiat Oncol Biol Phys 1996, 36:999–1004.

    Article  PubMed  CAS  Google Scholar 

  16. Al-Sarraf M, LeBlanc M, Giri PG, et al.: Chemoradio-therapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Inter-group Study 0099. J Clin Oncol 1998, 16:1310–1317.

    PubMed  CAS  Google Scholar 

  17. Vokes EE, Kies M, Haraf DJ, et al.: Induction chemo-therapy followed by concomitant chemoradiotherapy for advanced head and neck cancer: impact on the natural history of the disease. J Clin Oncol 1995, 13:876–883.

    PubMed  CAS  Google Scholar 

  18. Kies MS, Haraf DJ, Athanasiadis I, et al.: Induction chemotherapy followed by concurrent chemoradia-tion for advanced head and neck cancer: improved disease control and survival. J Clin Oncol 1998, 16:2715–2721.

    PubMed  CAS  Google Scholar 

  19. Vokes E, Kies M, Haraf D, et al.: Concomitant chemo-radiotherapy as primary therapy for locoregionally advanced head and neck cancer. J Clin Oncol 2000, 18:1652–1661.

    PubMed  CAS  Google Scholar 

  20. Kies MS: Combined therapy for squamous head and neck cancer [abstract]. Lung Cancer 1999, 25:228–229.

    Google Scholar 

  21. Brizel DM, Albers ME, Fisher SR, et al.: Hyperfraction-ated irradiation with or without concurrent chemo-therapy for locally advanced head and neck cancer. N Engl J Med 1998, 338:1798–1804.

    Article  PubMed  CAS  Google Scholar 

  22. Wendt TG, Grabenbauer GG, Rodel CM, et al.: Simulta-neous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study. J Clin Oncol 1998, 16:1318–1324. The authors reported a statistically significant 3-year survival advantage after concomitant use of simultaneous radiochemotherapy.

    PubMed  CAS  Google Scholar 

  23. Calais G, Alfonsi M, Bardet E, et al.: Randomized trial of radiation therapy versus concomitant chemo-therapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 1999, 91:2081–2086.

    Article  PubMed  CAS  Google Scholar 

  24. Jeremic B, Shibamoto Y, Milicic B, et al.: Hyperfraction-ated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial. J Clin Oncol 2000, 18:1458–1464. In this recent report, locoregional control, distant disease control, and overall survival were statistically improved at 5 years.

    PubMed  CAS  Google Scholar 

  25. Weinstein MC, Siegel JE, Gold MR, et al.: Recommenda-tions of the panel on cost-effectiveness in health and medicine. JAMA 1996, 276:1253–1258.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kies, M.S., Bennett, C.L. & Vokes, E.E. Locally advanced head and neck cancer. Curr. Treat. Options in Oncol. 2, 7–13 (2001). https://doi.org/10.1007/s11864-001-0012-x

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11864-001-0012-x

Keywords

Navigation